tbuckley/cabot-search huggingface dataset:
Neonatology-Perinatology
Journal: JAMA (2002)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
BOOK REVIEWS
Authors: M. L. LEVITT
Journal: JNCI Journal of the National Cancer Institute (1990)

BOOK REVIEWS Basic and Clinical Concepts of Lung Cancer . Heine H. Hansen , ed Dordrecht, The Netherlands : Kluwer Academic Publishers , 1989 , 368 pp. $125. MARK L. LEVITT MARK L. LEVITT Pittsburgh Cancer Institute230 Lothrop St. Pittsburgh, PA 15213 Search for other works by this author on: Oxford Academic PubMed Google Scholar JNCI: Journal of the National Cancer Institute, Volume 82, Issue 3, 7 February 1990, Page 228, https://doi.org/10.1093/jnci/82.3.228 Published: 07 February 1990
Intermittent Hydronephrosis
Authors: J. S. Ansell, James R. S. Paterson
Journal: New England Journal of Medicine (1962)

THE description of intermittent hydronephrosis is not new, the first case being recorded by Nicholas Tulpius1 in 1672. The subject was last thoroughly reviewed by D. F. Jones in 1909, but only scattered reports of this entity are found in the literature since 1935.Before the advent of pyelography such a diagnosis rested upon a history of intermittent pain and the demonstration, during attacks, of a tender renal mass that disappeared when the symptoms were relieved. The first retrograde pyelographic demonstration of intermittent obstruction of the ureteropelvic junction was by Papin2 in 1921. During an attempt at pyelography, while the . . .
Conduction Disturbances Traced To Infiltration
Journal: JAMA (1966)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Central venous catheter embolism.
Journal: BMJ (1978)

given that of five patients with deteriorating renal function, three were on gentamicin alone and two on gentamicin plus a cephalosporin.Of the three on gentamicin alone they say, "All three patients were also suffering from transplant rejection and toxaemia, and interpretation of these results is therefore difficult."Of the two on gentamicin plus a cephalosporin they say, "Although in both cases rejection was occurring, we could not exclude nephrotoxicity."They do not present any evidence to explain why in the one situation they conclude, "attributable nephrotoxicity not observed," while in the other they conclude, "may have produced nephrotoxicity."Furthermore, in view of the accumulating evidence that gentamicin appears to be potentially more nephrotoxic than some other aminoglycosidesl-3 attention might have been drawn to the fact that, whether or not it was attributable, all five patients who showed deteriorating renal function were actually receiving gentamicin and not one of the other aminoglycosides included in the study.
利用自噬作用消除转移性黑色素瘤中的丝裂原活化蛋白激酶抑制剂诱导的耐药性
Authors: S. Verykiou, M. Alexander, N. Edwards, R. Plummer, B. Chaudhry, P.E. Lovat, D.S. Hill
Journal: British Journal of Dermatology (2019)
Oncology
Authors: Teruhiko Yoshida
Journal: JAMA (1997)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
QuickStats: Distribution of Long-Term Care Staffing* Hours,†by Staff Member Type and Sector — United States, 2014
Journal: MMWR Morbidity and Mortality Weekly Report (2016)

In 2014, aides provided more hours of care in the major sectors of long-term care than the other staffing types shown. Aides accounted for 60% of all staffing hours in nursing homes, compared with licensed practical or vocational nurses (21%), registered nurses (13%), activities staff members (5%), and social workers (2%). Aides accounted for 75% of all staffing hours in residential care communities, in contrast to activities staff members (11%), registered nurses (7%), licensed practical or vocational nurses (6%), and social workers (1%). In adult day services centers, aides provided 41% of all staffing hours, followed by activities staff members (32%), registered nurses (12%), licensed practical or vocational nurses (9%), and social workers (6%).
Progressive myelopathy
Journal: JAMA (1985)

<h3>To the Editor.—</h3> In the article entitled "Progressive Myelopathy in a 32-Year-Old Man," Dr Chintapalli<sup>1</sup>draws attention to myelopathy caused by ossification of the lower thoracic ligamentum flavum. Although an uncommon occurrence, this entity is an important cause of thoracic cord myelopathy. Whereas this entity can be easily overlooked unless carefully sought for on conventional roentgenograms, it is recognized readily on computed tomographic (CT) scanning. <h3>Report of a Case.—</h3> We recently encountered the case of a 63-year-old man who was initially seen with symptoms and signs pointing to a lower thoracic cord lesion. The patient was investigated from the beginning by magnetic resonance imaging (MRI). Magnetic resonance imaging revealed a low-intensity signal lesion localized to a small part of the dorsal thoracic cord at the T-10 level (Fig 1). This lesion was interpreted as a small vascular lesion, perhaps an arteriovenous malformation (AVM). The physicians requested us to perform spinal
Reply
Authors: Maria I. Montañez, Angela Martín-Serrano, Cristobalina Mayorga, Esther Barrionuevo, Natalia Pérez, Antonino Romano, Esther Moreno, Adriana Ariza, Ezequiel Pérez-Inestrosa, Maria J. Torres
Journal: Journal of Allergy and Clinical Immunology (2020)
Cardiovascular Disorders
Authors: John A. Callahan
Journal: JAMA (1969)

This textbook attests to the rapid and diverse growth of the field of cardiovascular disorders in the last 10 to 15 years. Drs. Brest and Moyer have done a monumental job of collecting contributions and of editing to get this much information into one text. This serious attempt to be comprehensive, on a multipleauthor basis, sets this work apart from others on the subject. The text is divided into five parts, which allows for good presentation of basic knowledge, ample overlap, and some variation in approach. The first, "Normal and Pathologic Physiology," I personally found most attractive. Part 2, "Diagnostic Studies," ranges from physical examination to detailed discussions of laboratory procedures. This area has some very strong sections and some weak ones. Some of the weakness is unavoidable, for topics such as electrocardiography and roentgenologic examination of the heart need separate books for adequate presentation. Part 3, "Clinical Pharmacology," makes
Osleriana
Journal: JAMA (1988)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Hepatoma metastasis to bone
Authors: G. S. Sidhu
Journal: JAMA (1971)

<h3>To the Editor.—</h3> A basic answer to "Cholecystectomy in Patient with Endocardial Demand Pacemaker" (<b>217</b>:832, 1971) is that cholecystectomy can be accomplished safely without the use of electrocautery. That technique is a nonessential convenience to the surgeon. Where increased risk is suspected, good judgement dictates omission of the questioned technique.
Physiology
Authors: Hebbel E. Hoff
Journal: New England Journal of Medicine (1946)

Toxic and Hepatic Factors in ShockIt is now generally agreed that the primary factor in the development of the shock syndrome is a reduction in the effective volume of circulating blood. Whether through hemorrhage, vasodilatation in traumatized regions of the body or loss of fluid through damaged blood vessels in those areas, a discrepancy between the capacity of the vascular system and the amount of blood available to fill it occurs, and the blood pressure falls. If this discrepancy is too great, the body's compensatory mechanisms are overwhelmed, and death quickly follows. With a somewhat lesser degree of oligemia . . .
Safety Caps
Authors: Jay M. Arena
Journal: JAMA (1981)

<h3>To the Editor.—</h3> Sam Vee's "Coping With Caps" (1981;245:2525) clearly defines the public's disenchantment with the current safety-packaging. Unfortunately, he failed to point out that the Poison Prevention Packaging Act of 1970 allows each manufacturer of a product to provide one package in a noncomplying container. In addition, any pharmacist may dispense a noncomplying drug package to any patient at his request or at the request of his physician. It does not require a handwritten note, simply a request by any adult who has difficulty in opening the usual child-resistant packages. The fault lies in the failure of the medical and pharmacy professions in educating the public that safety packaging for drugs and household products, with potential toxic chemicals, provides a useful, practical, and indispensable measure in prevention of child poisoning and that the arthritic, disabled, or elderly can readily have the noncomplying package for his drug and household needs
Modeling of Exposure to Carpet-Cleaning Chemicals Preceding Irritant-Induced Asthma in One Patient
Authors: Richard M. Lynch
Journal: Environmental Health Perspectives (2000)

42-year-old woman experienced an acute asthma attack, seizures, and unconsciousness immediately after a carpet-cleaning and deodorizing job was conducted in her home. Exposure modeling estimates that she was exposed to approximately 3.4-17 mg/m(3) of sodium tripolyphosphate and more than 14 mg/m(3) volatile organic compounds immediately after the cleaning. I derived two separate exposure models for these estimates that evidenced good consistency of exposure estimates. Asthmatics and carpet-cleaning companies should be advised about safety during carpet-cleaning operations, including adequate warnings about excess risk for asthmatics, temporary removal from the home, reduced detergent levels within cleaners, and reduced overall levels of cleaning solutions used within the home. Further studies of carpet-cleaning exposures are indicated.
Experimental Evidence of Potential Blood Flow from Vein to Capillary Bed in the Brain
Journal: JAMA (1963)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
The evolution of debulking nephrectomy and patient characteristics in metastatic renal cell cancer patients enrolled into first-line tyrosine kinase inhibitors clinical trials.
Authors: Avishay Sella, Kongming Wang, Tal Sella
Journal: Journal of Clinical Oncology (2014)

513 Background: The introduction of tyrosine kinase inhibitors (TKIs) revolutionized treatment of metastatic renal cell cancer (mRCC). The role of debulking nephrectomy (DN) still remains unresolved. We reviewed the rate of DN and characteristics of patients enrolled in prospective clinical trials with TKIs through and after 2007 (Motzer, N Engl J Med, 2007). Methods: PubMed, Cochrane library, ASCO and ESMO web sites were searched for phase I-III clinical trials with at least 15 patients of first line TKIs administered alone/combination for mRCC. Expanded access/randomized discontinuation trials were excluded. We used PRISMA guidelines for data collection. All trials included histology, DN, prior cytokine therapy and efficacy data. Trials missing either performance status (PS) or MSKCC criteria data were included. We reviewed 72 trials; 42 trials are included: Group 1: 22 (phase I/II-19, phase III-3) trials completed through 2007 with 2,355 patients, Group 2: 20 trials (phase I/II-17, phase III-3) completed after 2007 with 3,719 patients. Thirty trials with 1,055 patients, all phase I/II, were excluded. Group characteristics were compared using a Pearson Chi-square test at a 2-sided significance level of 0.05, median progression free survival (PFS) with available 95% CI were compared using weighted T-Test. Results: Group 2 had statistically significantly (p&lt;0.001) less DN (85.7% vs 93.7%), less prior cytokine therapy (11.7% vs 46.8%), more poor prognosis (9.8% vs 4.0%), and intermediate prognosis characteristics (56.0% vs 51.9%), more PS 2 (2.8% vs 0.8%), and a similar rate of clear cell histology (97.9% vs 97.2%, p=0.097). Clinical objective response per intent to treat analysis was higher in Group 2 (28.6% vs 23.1%, p&lt;0.001) with similar clinical benefit (73.2% vs 75.3%, p=0.074) and comparable PFS (median 9 vs 8.2 months, p = 0.2528). Conclusions: The use of debulking nephrectomy in patients participating in clinical trials has declined in the TKIs era. More patients with worse prognostic parameters participated in TKI trials after 2007. The reduction in prior cytokine therapy prevents estimation of these changes on TKI efficacy.
Cricket
Authors: P. C. Rushton
Journal: BMJ (1957)

<h3>Aim</h3> To determine the 2-year outcomes of intravitreal bevacizumab (IVB) injections in eyes with macular oedema (ME) following branch retinal vein occlusion (BRVO). <h3>Methods</h3> Of 105 consecutive eyes (105 treatment-naïve patients) with ME following BRVO, 89 eyes were followed for 2 years after the first injection. During the 2-year follow-up period, patients were examined at least every 3 months and received an IVB injection (1.25 mg/0.05 mL) if they met prespecified retreatment criteria. Rescue grid laser was permitted based on the findings of the Branch Vein Occlusion Study. <h3>Results</h3> The baseline logarithm of the minimum angle of resolution visual acuity (VA) was 0.64±0.24 (mean±SD), which significantly (p=0.001) improved 1 month after the first injection to 0.39±0.22. One year after the first injection, VA improved significantly (p=0.001) to 0.33±0.21 and remained 0.34±0.21 until 2 years after the first injection (p=0.001). The changes in foveal thickness were correlated with those of VA during the 2-year follow-up period with a mean of 3.8±1.5 injections (including the first injection). <h3>Conclusions</h3> This relatively large case series study showed favourable 2-year outcomes using bevacizumab to treat ME following BRVO. Bevacizumab provides substantial long-term benefits in the treatment of ME following BRVO.
Cyclosporiasis Outbreaks Traced to Salad Mix and Cilantro in Salsa
Journal: JAMA (2014)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Personality Disorders
Authors: Robert Kellner
Journal: Psychotherapy and Psychosomatics (1986)

There is considerably less research on the treatment of personality disorders than most other disorders in psychiatry such as depression, anxiety or schizophrenia. There are several published review papers on research of the treatment of these disorders. The present brief survey will deal with the treatment of syndromes for which there is some research evidence of efficacy; for the most part, it deals with the treatment of unwanted emotions and behaviors that can occur in more than one diagnostic category.
CHRONIC SUPRARENAL INSUFFICIENCY AS A CAUSE OF NEURASTHENIA.
Journal: JAMA (1907)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Daily Pollen Counts: How Guilty?
Journal: JAMA (1966)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal